Standards for PET image acquisition and quantitative data analysis
R Boellaard - Journal of nuclear medicine, 2009 - Soc Nuclear Med
Quantitative 18 F-FDG PET is increasingly being recognized as an important tool for
diagnosis, determination of prognosis, and response monitoring in oncology. However, PET …
diagnosis, determination of prognosis, and response monitoring in oncology. However, PET …
[HTML][HTML] Review of osteosarcoma and current management
RA Durfee, M Mohammed, HH Luu - Rheumatology and therapy, 2016 - Springer
Osteosarcoma is the most common primary malignancy of bone in children and young
adults. This tumor has a very heterogeneous genetic profile and lacks any consistent …
adults. This tumor has a very heterogeneous genetic profile and lacks any consistent …
In vivo imaging of glucose uptake and metabolism in tumors
S Walker-Samuel, R Ramasawmy, F Torrealdea… - Nature medicine, 2013 - nature.com
Tumors have a greater reliance on anaerobic glycolysis for energy production than normal
tissues. We developed a noninvasive method for imaging glucose uptake in vivo that is …
tissues. We developed a noninvasive method for imaging glucose uptake in vivo that is …
Osteosarcoma
DD Moore, HH Luu - Orthopaedic oncology: primary and metastatic tumors …, 2014 - Springer
Osteosarcoma is a malignant tumor that primarily affects the long bones but can also involve
other bones in the body. It has a bimodal distribution with peaks in the second decade of life …
other bones in the body. It has a bimodal distribution with peaks in the second decade of life …
Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in …
SM Larson, Y Erdi, T Akhurst, M Mazumdar… - Clinical Positron …, 1999 - Elsevier
“Functional” tumor treatment response parameters have been developed to measure
treatment induced biochemical changes in the entire tumor mass, using positron emission …
treatment induced biochemical changes in the entire tumor mass, using positron emission …
Anatomy of SUV
SC Huang - Nuclear medicine and biology, 2000 - Elsevier
Standardized uptake value (SUV) for [F-18] fluorodeoxyglucose (FDG) studies that is
commonly used to differentiate malignant from benign tumors and to assess the efficacy of …
commonly used to differentiate malignant from benign tumors and to assess the efficacy of …
FDG-PET for clinical use: results of the 3rd German Interdisciplinary Consensus Conference," Onko-PET III", 21 July and 19 September 2000
SN Reske, J Kotzerke - European journal of nuclear medicine, 2001 - Springer
Positron emission tomography (PET) is the most powerful molecular imaging technique
currently available for clinical use. Because deranged tumour metabolism is a common …
currently available for clinical use. Because deranged tumour metabolism is a common …
Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography
H Vesselle, RA Schmidt, JM Pugsley, M Li… - Clinical Cancer …, 2000 - AACR
Tumor proliferation has prognostic value in resected early-stage non-small cell lung cancer
(NSCLC). We evaluated whether [F-18] fluorodeoxyglucose (FDG) uptake of NSCLC …
(NSCLC). We evaluated whether [F-18] fluorodeoxyglucose (FDG) uptake of NSCLC …
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
E Bastiaannet, H Groen, PL Jager, DCP Cobben… - Cancer treatment …, 2004 - Elsevier
Background: Sarcomas represent a significant diagnostic and therapeutic challenge that
requires techniques to provide better assessment of the disease than provided by traditional …
requires techniques to provide better assessment of the disease than provided by traditional …
Soft tissue sarcomas of adults: state of the translational science
EC Borden, LH Baker, RS Bell, V Bramwell… - Clinical cancer …, 2003 - AACR
Sarcomas—like leukemias, which are also mesodermal malignancies—carry biological
significance disproportionate to their clinical frequency. Identification of mutations and …
significance disproportionate to their clinical frequency. Identification of mutations and …